Buprenorphine differentially alters opioid receptor adaptation in rat brain regions

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 3, 1996, Pages 1322-1327

  Belcheva, Mariana M ^a   Ho, Matthew T ^a   Ignatova, Elena G ^a   Jefcoat, Laura B ^a   Barg, Jacob ^a,b,c   Vogel, Zvi ^b   McHale, Robert J ^a   Johnson, Frank E ^a   Coscia, Carmine J ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c Therapeut Comm Ramot Yehuda Z ^*  (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; BUPRENORPHINE; DELTA OPIATE RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; BRAIN STEM; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG ABUSE; DRUG RECEPTOR BINDING; FRONTAL CORTEX; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; OCCIPITAL CORTEX; PARIETAL LOBE; PRIORITY JOURNAL; RAT; THALAMUS;

ADAPTATION, PHYSIOLOGICAL; ANALGESICS; ANIMALS; BRAIN; BUPRENORPHINE; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; KINETICS; MALE; OLIGOPEPTIDES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID;

EID: 0030436903     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. 2-adrenergic receptor sequestration. J. Biol. Chem. 269: 2790-2795, 1994.
2. BELCHEVA, M. M., BARG, J., GLOECKNER, C., GAO, X.-M., CHUANG, D. M. AND COSCIA, C. J.: Antagonist-induced transient down-regulation of δ opioid receptors in NG108-15 cells. Mol. Pharmacol. 42: 445-452, 1992.
3. BELCHEVA, M. M., BARG, J., MCHALE, R. J., DAWN, S., Ho, M., IGNATOVA, E. AND COSCIA, C. J.: Differential down- and up-regulation of rat brain opioid receptor types and subtypes by buprenorphine. Mol. Pharmacol. 44: 173-179, 1993.
4. BELCHEVA, M. M., BARG, J., MCHALE, R. J. AND COSCIA, C. J.: Naltrexone induces down- and up-regulation of δ opioid receptors in rat brain regions. Brain Res. Bul. 35: 69-72, 1994.
5. BHARGAVA, H. N. AND GULATI, A.: Down-regulation of brain and spinal cord μ-opiate receptors in morphine tolerant-dependent rats. Eur. J. Pharmacol. 190: 305-311, 1990.
6. BIDLACK, J. M., ABOOD, L. G., OSEI-GYIMAH, P. AND ARCHER, S.: Purification of the opiate receptor from rat brain. Proc. Natl. Acad. Sci. U.S.A. 78: 636-639, 1981.
7. CHANG, K. J., ECKEL, R. W. AND BLANCHARD, S. G.: Opioid peptides induce reduction of enkephalin receptors in cultured neuroblastoma cells. Nature 296: 446-448, 1982.
8. COWAN, A., LEWIS, J. W. AND MACFARLANE I. R.: Agonist and antagonist properties of buprenorphine, a new antinociceptive agent. Br. J. Pharmacol. 60: 537-545, 1977.
9. DINGLEDINE, R., VALENTINO, R. J., BOSTOCK, E., KING, M. E. AND CHANG, K.-J.: Down-regulation of δ but not μ opioid receptors in the hippocampal slice associated with loss of physiological response. Life Sci. 33: 333-336, 1983.
10. DUM, J. E. AND HERZ, A..: In vivo receptor binding of the opiate partial agonist, buprenorphine, correlated with its agonistic and antagonistic actions. Br. J. Pharmacol. 74: 627-633, 1981.
11. EVANS, C. J., KEITH, D. E., MORRISON, H., MAGENDZO, K. AND EDWARDS, R. H.: Cloning of a delta opioid receptor by functional expression. Science 258: 1952-1955, 1992.
12. FUJIOKA, T., INOUE, F. AND KURIYAMA, M.: Purification of opioid-binding materials from rat brain. Biochem. Biophys. Res. Commun. 131: 640-646, 1985.
13. HAMMER, R. P.: Cocaine alters opiate receptor binding in critical brain reward regions. Synapse 3: 55-60, 1989.
14. HOWARD, A. D., DELA BAUME, S., GIOANNINI, T. L., HILLEH, J. M. AND SIMON, E. J.: Covalent labeling of opioid receptors with radioiodinated human β-endorphin. J. Biol. Chem. 260: 10833-10839, 1985.
15. JOHNSON, R. E., JAFFE, J. H. AND FUDALA, P. J.: A controlled trial of buprenorphine treatment for opioid dependence. JAMA 267: 2750-2755, 1992.
16. KAJIWARA, M., AOKI, K., ISHII, K, NUMATA, H., MATSUMIYA, T. AND OKA, T.; Agonist and antagonist actions of buprenorphine on three types of opioid receptor in isolated preparations. Jpn. J. Pharmacol. 40: 95-101, 1986.
17. 125I-labeled human β-endorphin to cell lines possessing either μ- or δ-type opioid binding sites. Brain Res. 440: 280-284, 1988.
18. KIEFFER, B. L., BEFORT, K., GAVERIAUX-RUFF, C. AND HIRTH, C. G.: The δ-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. U.S.A. 89: 12048-12052, 1992.
19. KO, J. L., LEE, N. M. AND LOH, H. H.: A 25-kilodalton protein, with properties of a delta-opioid-binding site, in NG108-15 cell membranes. J. Biol. Chem. 267: 12722-12727, 1992.
20. KONG, H., RAYNOR, K., YASUDA, K., MOE, S. T., PORTOGHESE, P. S., BELL, G. I. AND REISINE, T.: A single residue, aspartic acid 95, in the δ opioid receptor specifies selective high affinity agonist binding. J. Biol. Chem. 268: 23055-23058, 1993.
21. KOSTEN, T. R., KLEBER, H. D. AND MORGAN, C.: Treatment of cocaine abuse with buprenorphine. Biol. Psychiatry 26: 637-639, 1989.
22. LEANDSR, J. D.: Buprenorphine has potent kappa opioid receptor antagonist activity. Neuropharmacology 26: 1445-1447, 1987.
23. 2-adrenergic receptor. Proc. Natl. Acad. Sci. U.S.A. 90: 3665-3669, 1993.
24. LOH, H. H., TAO, P. -L. AND SMITH, A. P.: Role of receptor regulation in opioid tolerance mechanisms. Synapse 2: 457-462, 1988.,
25. LOUKAS, S., MERCOURIS, M., PANETSOS, F. AND ZIOUDROU, C.: Purification to homogeneity of an active opioid receptor from rat brain by affinity chromatography. Proc. Natl. Acad. Sci. U.S.A. 91: 4574-4578, 1994.
26. LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. AND RANDALL, R. J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
27. MANSOUR, A., KHACHATURIAN, H., LEWIS, M. E., AKIL, H. AND WATSON, S. J.: Autoradiographic differentiation of μ, δ, and κ opioid receptors in the rat forebrain and midbrain. J. Neurosci. 7: 2445-2464, 1987.
28. MARTIN, W. R., EADES, C. G., THOMPSON, J. A., HUPPLER, R. E. AND GILBERT, P. E.: The effects of morphine and nalorphine-like drugs in the non-dependent and morphine-dependent chronic spinal dog. J. Pharmac. Exp. Ther. 197: 517-532, 1976.
29. 1251-β-endorphin to μ-opioid receptors during development. Dev. Brain Res. 45: 283-290, 1989.
30. MELLO, N. K. AND MENDELSON, J. H.: Buprenorphine suppresses heroin use by heroin addicts. Science 207: 657-659, 1980.
31. MIYAMOTO, Y., BOWEN, W. D., PORTOGHESE, P. S. AND TAKEMORI, A. E.: Lack of involvement of delta-1 opioid receptors in the development of physical dependence on morphine in mice. J. Pharmacol. Exp. Ther. 270: 37-39, 1994.
32. MORRIS, B. J., MILLAN, M. J. AND HERZ, A.: Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of μ, δ and κ binding sites in rat brain revealed by quantitative autoradiography. J. Pharmacol. Exp. Ther. 240: 729-736, 1988.
33. MUNSON, P. J. AND RODBARD, D.: LIGAND:a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107: 220-239, 1980.
34. NEGUS, S. S., PICKER, M. J. AND DYKSTRA, L, A.: Kappa antagonist properties of buprenorphine in non-tolerant and morphine-tolerant rats. Psychopharmacology 98: 141-143, 1989.
35. PADEN, C. M., KRALL, S. AND LYNCH, W. C.: Heterogeneous distribution and up-regulation of μ, δ and κ opioid receptors in the amygdala. Brain Res. 418: 349-355, 1987.
36. RICHARDS, M. L. AND SADEE, W.: Buprenorphine is an antagonist at the κ opioid receptor. Pharm. Rea. 2: 178, 1985.
37. ROTHMAN, R. B., Ni, Q. AND Xu, H.: Buprenorphine: A Review of the Binding Literature, In Buprenorphine, ed. by A. Cowan and J. W. Lewis, pp. 19-30, Wiley-Liss, New York, 1995.
38. SADEE, W., ROSENBAUM, J. S. AND HERZ, A.: Buprenorphine: Differential interaction with opiate receptor subtypes in vivo. J. Pharmacol. Exp. Ther. 223: 157-162, 1982.
39. 1251]β-endorphin to opioid receptors in rat striatal membranes:biochemical evidence for the existence of a μ/δ opioid receptor complex. J. Pharmacol. Exp. Ther. 253: 419-426, 1990.
40. STEECE, K. A., LEE, J. M., FIELDS, J. Z., DELEON-JONES, F. A. AND RITZMANN. R. F.: Differential down-regulation of δ opioid binding sites during physical dependence on methionine enkephalin in the rat. Life Sci. 44: 1449-1455, 1989.
41. TAO, P. -L., LAW, P. -Y. AND LOH, H. H.: Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment. J. Pharmacol. Exp. Ther. 240: 809-816, 1987.
42. 5]enkephalin treatment. Brain Res. 462: 313-320, 1988.
43. TEMPEL, A. E., GARDNER, L. AND ZUKIN, S.: Visualization of opiate receptor upregulation by light microscopy autoradiography. Proc. Natl. Acad. Sci. U.S.A. 81: 3893-3897, 1984.
44. TEMPEL, A., KESSLER, J. A. AND ZUKIN, R. S.: Chronic naltrexone treatment increases expression of preproenkephalin and preprotachykinin mRNA in discrete brain regions. J. Neurosci. 10: 741-747, 1990.
45. UNTERWALD, E. M., HORNE-KING, J. AND KREEK, M. J.: Chronic cocaine alters brain μ opioid receptors. Brain Res. 584: 314-318, 1992.
46. WERLNG, L. L., MCMAHON, P. N. AND COX, B. M.: Selective changes in μ opioid receptor properties induced by chronic morphine exposure. Proc. Natl. Acad. Sci. U.S.A. 86: 6393-6397, 1989.
47. ZADINA, J. E. AND KASTIN, A. J.: Neonatal peptides affect developing rats:β-endorphin alters nociception and opiate receptors, corticotropin-releasing factor alters corticosterone. Dev. Brain Res. 29: 21-29, 1986.